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Single-gene disorders offer unique opportunities to shed light upon fundamental physiological processes in humans.We investigated an
autosomal-recessive phenotype characterized by alopecia, progressive neurological defects, and endocrinopathy (ANE syndrome). By
using homozygosity mapping and candidate-gene analysis, we identiﬁed a loss-of-function mutation in RBM28, encoding a nucleolar
protein. RBM28 yeast ortholog, Nop4p, was previously found to regulate ribosome biogenesis. Accordingly, electron microscopy
revealed marked ribosome depletion and structural abnormalities of the rough endoplasmic reticulum in patient cells, ascribing ANE
syndrome to the restricted group of inherited disorders associated with ribosomal dysfunction.Introduction
The nucleolus is associatedwith the regulation of a number
of major physiological cellular processes including ribo-
some assembly, cell mitosis, stress response, and genera-
tion of ribonucleoprotein complexes.1 More than 700 nu-
cleolar proteins have been identiﬁed in humans,2,3 most of
which seem to be involved in the processing and matura-
tion of ribosomal RNAs (rRNAs) and in the generation of
mature ribosomes.1 Despite major advances in our under-
standing of the nucleolus role, much uncertainty remains
concerning the precise physiological importance of indi-
vidual constituents of the various nucleolar complexes,
possibly as a result of the fact that in vitro systems used
to probe nucleolar-protein function often lack direct rele-
vance to in vivo physiological conditions. More speciﬁ-
cally, very little is currently known about the pathophysi-
ological consequences resulting from nucleolar-protein
defective function in humans. With the recognition of
the major limitations inherent to genetically engineered
mouse models, the study of rare inherited single-gene
disorders represents a powerful investigative tool for the
delineation of biological functions in humans.4,5 In the
present report, we characterize through the study of a
rare syndrome the clinical manifestations resulting from
decreased expression of RBM28, a recently described nucle-
olar component of the spliceosomal small nuclear ribonu-
cleoproteins (snRNPs).1114 The American Journal of Human Genetics 82, 1114–1121, MayMaterial and Methods
Patients
All affected and healthy control participants or their legal guard-
ian providedwritten and informed consent according to a protocol
approved by the institutional review board and by Israel National
Committee for Human Genetic Studies in adherence to the
Helsinki guidelines.
SNP Genotyping
Genome-wide homozygosity mapping was performed with the
Mapping NspI 250K Array Set from Affymetrix (Affymetrix).
Genomic DNA was digested with NspI, ligated to an adaptor,
and subjected to polymerase chain reaction (PCR) ampliﬁcation
with adaptor-speciﬁc primers. The PCR products were digested
with DNaseI and labeled with a biotinylated nucleotide analog.
The labeled DNA fragments were hybridized to the microarray,
stained by streptavidin-phycoerythrin conjugates, washed with
the Affymetrix Fluidics Station 450, and scanned with GeneChip
scanner 3000.
Microsatellite Analysis
Polymorphic microsatellite markers spanning the ANE syndrome
critical interval were selected from the GDB database; genotypes
were established by PCR ampliﬁcation of genomic DNA with Taq
polymerase, Q solution (QIAGEN) and ﬂuorescently labeled oligo-
nucleotide pairs (Syntezza Bioscience) according to the manufac-
turer’s recommendations. PCR conditions were 5 min at 95C;
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Table 1. ANE Syndrome: Clinical Delineation
Case 1 Case 2 Case 3 Case 4 Case 5
Sex male male male male male
Age (years) 39 36 30 27 20
MR severe moderate severe moderate severe
Alopecia universalis sparse hair trunk, axilla universalis partial universalis
Height in cm (centile) 150 (3.5 SD) 166 (7) 167 (8) 169 (10) 148 (3.5 SD)
Head circumference in cm (centile) 52.5 (2.5 SD) 55 (40) 52 (2.5 SD) 53.5 (5) 49.8 (3 SD)
Dental carries þþþ þþ þþþ þþþ þþþ
Hypodontia/early teeth loss yes no yes no yes
Gynecomastia þþþ þþþ þ þþ no
Kyphoscoliosis severe no moderate moderate moderate
Limb contractures þ no þþ þþþ þþ
Motor deterioration þþþ þ/ þþ þþ þþ
UMN dysfunction þþþ þ/ þþþ þþ þþþ
Muscle atrophy no no yes yes yes
Penile length 4 cm 8 cm 5 cm 9.5 cm 4 cm
Tanner stage 1 (prepubertal) 3–4 1 (prepubertal) 3 1 (prepubertal)
Hypogonadotropic
hypogonadism
yes yes yes yes yes
Central adrenal
insufficiency
yes yes yes yes yes
Brain CT ND ND normal normal normal
Brain MRI ND ND ND ND hypoplastic pituitary
Abbreviations are used as follows: MR, mental retardation; SD, standard deviation; UMN, upper motor neuron; and ND, not done.1 min 30 s at 72C and a ﬁnal extension step at 72C for 7 min.
PCR products were separated by PAGE on an ABI 310 sequencer
system, and allele sizes were determined with Genescan 3.1 and
Genotyper 2.0 software. Parsimonious haplotypes were subse-
quently established for each individual.
Mutation Analysis
RBM28was sequencedwith oligonucleotide primer pairs spanning
the entire coding sequence of the gene (Table S1 available online),
Taq polymerase, and Q solution (QIAGEN) with the following
cycling conditions: 94C for 5 min and then by 35 cycles at
95C for 30 s, 57C for 45 s, and 72C for 1 min 30 s. Gel-puriﬁed
(QIAquick gel extraction kit, QIAGEN) amplicons were subjected
to bidirectional DNA sequencing with the BigDye terminator
system on an ABI Prism 3100 sequencer (PE Applied Biosystems).
To screen for p.L351P mutation, we PCR ampliﬁed a 324bp frag-
ment, with forward primer 50-CAAGGGAGAGTTGATATCTAAC-30
and reverse primer 50-GCTGGATGGACTGTGAAC-30. The muta-
tion creates a recognition site for endonuclease BSAJI (New
England Biolabs). After incubation at 37C for 4 hr, digested PCR
products were electrophoresed in a 2% agarose gel.
Cell Cultures and Reagents
Fibroblast cell cultures were established from punch biopsies
obtained from two patients and two healthy controls after written
informed consent was obtained, and were maintained in DMEM
supplemented with 20% fetal calf serum, 1% L-Glutamine and
1% penicillin/streptomycin (Beit-Ha-Emek).
Quantitative RT-PCR
For quantitative real-time PCR, cDNAwas synthesized from 1 mg of
total RNA with the Reverse-iT ﬁrst-strand synthesis kit (ABgene)
and random hexamers. cDNA PCR ampliﬁcation was carried out
with the SYBR Green JumpStart Taq ReadyMix (Sigma) on
a Mx3000p/5p multi-ﬁlter system (Stratagene) with gene-speciﬁcThe Amintron-crossing oligonucleotide pairs (Table S2). To ensure the
speciﬁcity of the reaction conditions, at the end of the individual
runs, we measured the melting temperature (Tm) of the ampliﬁed
products to conﬁrm its homogeneity. Cycling conditions were as
follows: 95C for 10 min and 95C for 10 s, 62C for 15 s, and
72C for 25 s for a total of 40 cycles. Each sample was analyzed
in triplicate. For quantiﬁcation, standard curves were obtained
with serially diluted cDNA ampliﬁed in the same real-time PCR
run. Results were normalized to ACTB and GAPDH mRNA levels.
Immunoﬂuorescence Microscopy
Fibroblast cells were grown on glass coverslips, ﬁxed with 4% para-
formaldehyde, and incubated with a rabbit polyclonal antibody
against RBM286 for 60 min at 20C. Staining was detected after
incubation with Cy2-conjugated goat anti-rabbit IgG (Jackson
Immunoresearch Laboratories). The slides were observed under
a confocal microscope (Axiovert 200M LSM 510 Meta, Carl Zeiss
MicroImaging GmbH) with Image-Pro Plus LSM image examiner
software (Media Cybernetics).
Immunohistochemistry
Formaldehyde-ﬁxed 5 mmparafﬁn-embedded sectionswere treated
with 3% H2O2 in methanol for 15 min at room temperature,
warmed in a microwave oven in citrate buffer for 15 min at 90C,
and stainedwithpolyclonal anti-RBM28, anti-b-catenin antibodies
(Abnova Corporation) or preimmune rabbit antiserum for 1 hr at
room temperature. After extensivewashings in phosphate buffered
saline, the antibodies were revealed with the ABC technique
(Zymed), and the slides were counterstained with hematoxylin.
Western Blotting
Cells were homogenized in lysis buffer (25 mM HEPES, 300 mM
NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, and protease inhibitors
mix including 1 mM PMSF, 1 mg/ml aprotinin, and leupeptin;
Sigma, St Louis, MO, USA) or directly in loading buffer (100 mMerican Journal of Human Genetics 82, 1114–1121, May 2008 1115
Figure 1. Clinical Features of ANE
Syndrome
Patients display varying patterns of alope-
cia including (A) alopecia universalis, (B)
hypotrichosis, (C) near-normal scalp hair
associated with absence of body and (D)
axillary hair; additional features include
(E) gynecomastia, (F) flexural reticulate
hyperpigmentation and (G) hypodontia
and tooth malplacement; (H) cerebral
MRI (T1 weighted after gadolinium injec-
tion) shows normal hypothalamus, hypo-
plastic thin anterior pituitary gland at
the bottom of the sella turcica (thick
arrow), and ectopic posterior pituitary
hyperintense signal located at a proximal
level of the pituitary stalk (thin arrow);
(I) a skin biopsy obtained from patient
scalp reveals absence of mature hair folli-
cles, and instead, presence of dermal cysts
(Cy) as well as elongated vertically ori-
ented epithelial structures associated
with sebaceous glands, corresponding to
rudimentary hair follicles (Rhf).Tris [pH 6.8], 4% SDS, 20% glycerol, and 0.2% Bromophenol blue).
After centrifugation at 10,000 g for 10 min at 4C, proteins were
electrophoresed through a 10% SDS-PAGE and transferred onto1116 The American Journal of Human Genetics 82, 1114–1121, Maa nitrocellulose membrane (Trans-Blot Bio-Rad). After 1 hr block-
ing with 13 TBS (20 mM Tris and 150 mM NaCl) with 5% skim
milk and 0.01% Tween 20, blots were incubated with primaryFigure 2. Genetic Mapping of ANE Syndrome
(A) Multipoint LOD score analysis in ANE syn-
drome. The LOD scores are plotted against the
physical distances separating the markers as-
sessed.
(B) Haplotype analysis of the ANE family with
polymorphic markers on chromosome 7q31.32-
7q32 reveals a homozygous haplotype shared by
all patients (boxed in red).y 2008
rabbit anti-RBM28 or mouse anti-b-actin antibodies (Aviva System
Biology and ABcam). The blots were washed three times with
TBS-Tween (20 mM Tris HCl, 4 mM Tris base, 140 mM NaCl,
1 mM EDTA, and 0.1% Tween-20). After incubation with second-
ary HRP-conjugated anti-rabbit or anti-mouse antibody (Sigma-
Aldrich) and subsequent washings, proteins were detected with
the EZ-ECL chemiluminescence detection kit (Biological
Industries).
Figure 3. Mutation Analysis
(A) Sequence analysis of RBM28 reveals a homozygous T/C tran-
sition at cDNA position 1052 of the RBM28 gene (red arrow, upper
panel). The wild-type sequence is given for comparison (lower
panel).
(B) PCR-RFLP analysis confirms segregation of the mutation in the
family. PCR amplification was performed as described in the text.
Mutation c.T1052C creates a recognition site for BSAJI. Thus,
affected patients display two 127 bp and 132 bp fragments
(appearing as one band) and healthy individuals show a 257 bp
fragment only, whereas all fragments are found in heterozygous
carriers of the mutation.The AmElectron Microscopy
Cell pellets were ﬁxed in half-strength Karnowski’s ﬁxative and 1%
osmium tetroxide. The pellets were dehydrated with ethanol and
embedded in EPON812 (Taab). Ultrathin sections were stained
with uranyl acetate and lead citrate.
Bioinformatics and Computational Modeling
Linkage analysis was performed with the Superlink platform.7
Sequence alignment was performed with MAFFT, a multiple-
sequence-alignment program. The sequence of the N-terminal
part of RBM28was modeled with the Phyre homology recognition
engine server.8
Results
ANE Syndrome: A Pleiotropic and Clinically
Heterogeneous Disorder
We assessed a consanguineous kindred of Arab Moslem
descent comprising ﬁve male individuals affected with
a complex syndrome consisting of alopecia, neurological
defects, and endocrinopathy (ANE syndrome) (Table 1).
Patients were found to display hair loss of widely varying
severity (Figures 1A–1D). A skin biopsy obtained from scalp
skin revealed absence of mature hair follicles; instead, only
rudimentary infundibula and epithelial cysts were ob-
served in the dermis (Figure 1I). Neurological impairment
consisted of moderate to severe mental retardation and
progressive motor deterioration, which started in all
affected siblings during their second decade of life. Progres-
sive motor decline was found to result from combined
upper and lower motor dysfunction. Extensive endocrino-
logical evaluation revealed central hypogonadotropic
hypogonadism manifesting with delayed or absent pu-
berty and central adrenal insufﬁciency. Brain magnetic
resonance imaging (MRI) revealed a hypoplastic pituitary
gland with preserved hypothalamus (Figure 1H) but no
evidence for basal ganglia or white-matter disease. Addi-
tional features included short stature, microcephaly,
gynecomastia (Figure 1E), ﬂexural reticulate hyperpigmen-
tation (Figure 1F), hypodontia (Figure 1G), kyphoscoliosis,
multiple facial pigmented nevi, ulnar deviation of hands,
and loss of subcutaneous fat.
A Deleterious Homozygous Mutation in RBM28
Underlies ANE Syndrome
To identify the ANE syndrome locus, we initially excluded
candidate regions previously linked to alopecia, alopeciaFigure 4. Tissue Expression of RBM28
RBM28 gene expression was assessed with
Clontech tissue blot cDNA array. The tissue
used in each lane is as follows: lane 1,
trachea; lane 2, thymus; lane 3, thyroid;
lane 4, testes; lane 5, spleen; lane 6,
muscle; lane 7, small intestine; lane 8, prostate; lane 9, heart; lane 10, ovary; lane 11, cervix; lane 12, bladder; lane 13, colon; lane
14, brain; lane 15, lungs; lane 16, liver; lane 17, kidney; lane 18, esophagus; lane 19, adipose tissue; and lane 20, placenta. Expression
of RBM28 was compared to that of ACTB.erican Journal of Human Genetics 82, 1114–1121, May 2008 1117
Figure 5. Consequences of p.L351P
Mutation in RBM28
(A) ClustalW analysis of the RBM28 protein
region encompassing the mutation site
demonstrates that L351 (boxed in red) is
conserved across species.
(B) The sequence of the N-terminal part of
RBM28 was modeled with the Phyre homol-
ogy recognition engine server with the
crystal structure of the N-terminal region
of the yeast RNA splicing factor Prp2426
(PDB code 2GHP). Four hundred and twenty
residues could be modeled in this fashion
with an extremely high degree of confi-
dence (E ¼ 1024). The Prp24 structure
includes three RNA recognition motifs
(RRM), consisting of a four-stranded
b sheet flanked by two a helices. Wild-
type L351 (white ellipse, left panel) is
located on the C-terminal end of helix 1
of RRM3 and is expected to destabilize
the protein a-helix 1 when mutated to
proline (white ellipse, right panel).
(C) Protein was extracted from fibroblast
cell cultures established from two ANE
patients (P1 and P2) and a control healthy
individual (C) and immunoblotted against
anti-RBM28 antibodies. Membranes were reblotted with anti-b-actin antibodies to control for protein loading.
(D) Cultured fibroblasts obtained from a patient (lower panel) and a control individual (upper panel) were stained with an anti-RBM28
antibody (green) and propidium iodide (red) and were examined with confocal microscopy. Merged images are presented. Note increased
focal expression of RBM28 in the nucleus of control cells and markedly decreased expression of the protein in patient cells.
(E) Skin-biopsy sections obtained from a patient (right panel) and a control individual (left panel) were stained with antibodies directed
against RBM28. Immunostaining is markedly decreased in the skin of the patient as compared with control skin (original magnification,
4003).with mental retardation, or alopecia associated with der-
mal cysts on histology as seen in our patients (Figure 1I)
on 3q26.2-q26.31, 3q26.33-q27.3, 8p12, 12q13.11, and
18q11.2-q12.29–12 (not shown). We then genotyped all
affected individuals for 250K SNP markers distributed
across the genome and identiﬁed a single 6.45 Mb region
of homozygosity on 7q31.32-7q32 shared by all patients.
By using microsatellite markers spanning the disease inter-
val, we conﬁrmed a gene locus for ANE syndrome in this
region, with a maximum multipoint LOD score of 3.64
(q ¼ 0.0) at marker D7S530 (Figure 2A). Haplotype analysis
(Figure 2B) deﬁned a critical ~6 Mb interval between
rs17147033 and rs205763. This interval was found to
contain 72 genes, of which 24 were fully sequenced.
A homozygous T/C transition was identiﬁed at cDNA
position 1052 of the RBM28 gene (c.T1052C) (Figure 3A).
This mutation is predicted to result in the nonconservative
substitution of a proline for a leucine residue at amino acid
position 351 of the RBM28 protein (p.L351P). By using
a PCR-RFLP assay, we found p.L351P to segregate in the
family in an autosomal-recessive manner (Figure 3B). We
excluded the mutation from a panel of 600 population-
matched healthy controls (1200 chromosomes), suggest-
ing that c.T1052C does not represent a common neutral1118 The American Journal of Human Genetics 82, 1114–1121, Mapolymorphism (not shown) but rather is a disease-causing
mutation.
The RBM28 gene encodes an 85 kDa protein recently
found to be part of the mammalian snRNP complexes
and comprising four RNA recognition motifs (RRMs 1–4)
as well as an extremely acidic region of 32 amino acids
between RRM2 and RRM3.6 RBM28 was observed to be
expressed ubiquitously (Figure 4). Mutation p.L351P was
found to affect a highly conserved residue located within
the RRM3 domain (Figure 5A). The RRM3 motif consists
of a four-stranded b sheet ﬂanked by two a helices. L351
is located at the C-terminal end of RRM3 helix 1, directly
preceding a very tight loop leading to b strand 2 and
containing four contiguous Glu residues. Computational
modeling showed that p.L351P is predicted to signiﬁcantly
compromise the integrity of RBM28 structure (Figure 5B).
To assess the consequences of p.L351P in vivo, we ascer-
tained RBM28 expression in ﬁbroblasts derived from ANE
patients and normal control individuals. Although the
mutation was found to lack any signiﬁcant effect on
mRNA expression as assessed by quantitative RT-PCR
(not shown), we found that RBM28 was barely detectable
by immunoblotting in ﬁbroblasts derived from patient
skin (Figure 5C), suggesting that p.L351P results in proteiny 2008
destabilization and degradation as predicted by computa-
tional modeling (Figure 5B). At the cellular level, immuno-
ﬂuorescence staining of control ﬁbroblasts revealed focal
expression of RBM28 in the nucleus mainly and, less con-
spicuously, in the cytoplasm. In contrast, RBM28 was
barely detectable in patient ﬁbroblasts (Figure 5D). More-
over, immunostaining of patient epidermis revealed
decreased expression of RBM28 in the patient skin (Fig-
ure 5E). These data suggested a loss-of-function effect of
the mutation, although in the absence of a better under-
standing of RBM28 function, the remote possibility of
a gain-of-function effect cannot be entirely dismissed.
Figure 6. Ultrastructural Abnormalities Associated with
RBM28 Deficiency
(A) Transmission electron microscopy (TEM) of cultured fibroblasts
in a patient (right panels) and a healthy control individual (left
panels) revealed dilated cisterns of the rough endoplasmic reticu-
lum (RER, upper panels) and decreased number of free ribosomes
(red circles, lower panels) in the patient cells. The rectangles in
the upper panels correspond to the magnified electron micrographs
shown in the lower panels.
(B) Free cytoplasmic ribosomes were counted at a TEM magnifica-
tion of 400003 in control and patient fibroblasts in six indepen-
dent samples (>1500 ribosomes counted in each group). Results
are given as number of free ribosomes per mm2 5 SE. Statistical
differences were assessed with a paired Student’s t test.The AmRibosome Depletion in ANE Syndrome
Because the RBM28 yeast ortholog Nop4p has been shown
to be essential for proper ribosome biogenesis,13 we as-
sessed the effect of RBM28 deﬁciency on ribosome distri-
bution at the ultrastructural level. We observed strikingly
abnormal structure of the rough endoplasmic reticulum
(RER) in patient cells as compared with control ﬁbroblasts
(Figure 6A). In addition, ribosome density was signiﬁcantly
lower in cells derived from patient skin as compared with
control cells (Figures 6A and 6B). In contrast, shape and
size of nucleolar ﬁbrillar centers, dense ﬁbrillar compo-
nents, and granular components in patient ﬁbroblasts
appeared to be not different from those of control subjects
(data not shown).
Discussion
In the present study, we describe the clinical manifesta-
tions and delineate the molecular basis of ANE syndrome,
a complex pleiotropic disorder. The absence of structural
abnormalities on brain MRI and the type of endocrine de-
fects found in patients distinguishes ANE syndrome from
other rare phenotypes previously reported including
Woodhouse-Sakati syndrome (MIM 241080) and John-
son-McMillin syndrome (MIM 147770).14–17 A homozy-
gous missense mutation in RBM28 was found to segregate
with the disease and to result in loss of protein expression
in patient ﬁbroblasts and epidermis. In spite of its ubiqui-
tous pattern of expression, RBM28 deﬁciency results in
a disease phenotype conﬁned to a limited number of tis-
sues, possibly reﬂecting functional redundancy among
snRNA binding proteins, as previously shown for muta-
tions affecting other nucleolar proteins.18
The precise role played by RBM28 is still poorly under-
stood. RBM28 has been found in association with snRNAs,
suggesting that it may be involved in snRNPmaturation or
be part of the spliceosomal machinery.6 However, its yeast
ortholog, Nop4p, has been shown to be required during
the biogenesis and assembly of ribosomal subunits.13 Actu-
ally, a deleterious mutation in the RRM3 domain of Nop4p
was found to result in ribosome depletion, due to defective
assembly of the 60S subunit,13 an observation that is in
line with the effect of RBM28 deﬁciency in human cells
(Figure 5C). Other nucleolar snRNA-associated proteins,
such as Prp43p, a DEAH-box spliceosome disassembly
factor, have similarly been found to be essential for both
ribosome biogenesis as well as spliceosome dynamics.19
Although inhibition of ribosome biogenesis may directly
cause decreased cell proliferation and thus explain the de-
velopmental abnormalities observed in ANE syndrome,
a recent study suggested that nucleolar stress may result
in p53 stabilization, ensuing in cellular loss and tissue
dysplasia.20
Regardless of the exact function of RBM28 during the
formation of mature ribosomes, the present study clearly
indicates that this protein is at least required for the correcterican Journal of Human Genetics 82, 1114–1121, May 2008 1119
development of three major physiological systems: the
hair follicle, the hypothalamic-hypophyseal axis, and the
nervous system. Although the role of RNP complexes dur-
ing neural ontogenesis has been well established,21 the
essential function played by RBM28 during hair-follicle
formation is puzzling. The absence of mature hair follicles
and the conspicuous presence of dermal cysts on histopa-
thology in ANE syndrome skin are reminiscent of the
features seen in mice lacking b-catenin epidermal expres-
sion22 and in humans affected with atrichia with papular
lesions (APL; MIM 209500).11 APL is caused by defective
function of hairless, a protein responsible for promoting
WNT signaling,23 which in turn results in stabilization of
b-catenin. Interestingly, immunohistochemistry per-
formed on skin biopsies obtained from ANE syndrome
patients revealed markedly decreased expression of b-cate-
nin (not shown). Moreover, recent data indicate that b-cat-
enin plays a key role in determining pituitary develop-
ment;24 these observations may help understanding
endocrine functional (Table 1) and structural (Figure 1H)
anomalies found in ANE syndrome. Taken together, these
data suggest a hitherto unrecognized role for RBM28 dur-
ing hair formation, probably related to the hairless/WNT/
b-catenin signaling pathway.
In conclusion, the present data provide strong evidence
for RBM28 involvement in the development of the neural
system, the pituitary gland, and the hair follicle, as well as
demonstrate its importance for proper ribosome biogene-
sis. Hence, ANE syndrome can be added to the short but
steadily expanding list of human inherited diseases associ-
ated with ribosomal abnormalities.25
Supplemental Data
Two tables are available at http://www.ajhg.org/.
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